In this biography
Quick facts
- Born
- 13 August 1918
- Died
- 19 November 2013
- Birthplace
- Rendcombe, Gloucestershire, England
- Country
- United Kingdom
- Nationality
- Not independently established
- Known for
- Insulin amino-acid sequence and methods for sequencing nucleic acids
- First Nobel Prize
- Chemistry, 1958: protein structure, especially insulin
- Second Nobel Prize
- Chemistry, 1980: nucleic-acid sequencing
- LMB move
- 1962
- Retirement
- 1983
Why this life matters
Frederick Sanger developed ways to determine the order of components in proteins and nucleic acids. His two chemistry Nobel Prizes mark different stages of a research career whose continuity was the problem of sequence and whose methods depended on many collaborators.
Timeline
Key moments
Born in Rendcombe
Born on 13 August.
Cambridge BA
Completed his undergraduate degree.
Research transition
After doctoral work with Neuberger, joined Chibnall’s protein group.
First Nobel Prize
Recognised for protein structure research, especially insulin.
Laboratory of Molecular Biology
Moved to the new MRC laboratory.
Plus-and-minus method
Published with Alan Coulson.
Chain-termination paper
Published with Steve Nicklen and Alan Coulson.
Second Nobel Prize
Shared the chemistry award with Paul Berg and Walter Gilbert.
Death
Died on 19 November.
Training for research rather than medical practice
Frederick Sanger was born in Rendcombe, Gloucestershire, on 13 August 1918. His father was a doctor, but Sanger decided before university that experimental science would suit him better than medicine. At St John’s College, Cambridge, he became interested in biochemistry. He completed his BA in 1939 and continued with an advanced course before undertaking doctoral research with Albert Neuberger.
His doctorate examined metabolism rather than the DNA method for which his name is now widely used. In 1943 he joined Charles Chibnall’s group to study proteins, including insulin. Sanger’s own biography describes Neuberger’s teaching as important both for practical technique and for learning how to conduct research. The later achievements grew from that training, not from an early certainty about a final sequencing machine.
What sequencing insulin meant
Protein sequencing addresses the order of amino acids, rather than simply identifying which amino acids a sample contains. Insulin offered Sanger and colleagues a defined molecule on which to develop methods. New separation techniques and chemical analysis made it possible to compare fragments and reconstruct their sequence. The 1958 chemistry Nobel Prize recognised this work on protein structure, particularly insulin.
This was a different kind of information from a crystallographic model. A sequence sets out an ordered chemical chain; a three-dimensional structure addresses how that chain is arranged in space. Sanger’s later move from protein to nucleic acid research changed the material under investigation while preserving the central question of order.
A laboratory and a succession of methods
Sanger joined the Medical Research Council staff in 1951 and moved to the new Laboratory of Molecular Biology in 1962. He worked among researchers with different experimental backgrounds and explicitly credited long-term colleagues including Brian Barrell, Alan Coulson and George Brownlee. His research was not the solitary design of every step in modern genomics.
The 1975 plus-and-minus method with Coulson used polymerase copying to obtain sequence information. The 1977 chain-termination paper had three authors: Sanger, Steve Nicklen and Coulson. It investigated both dideoxy and arabino nucleotide analogues. In his 1988 recollection, Sanger described Nicklen’s work on the arabino alternatives and the assistance of researchers who supplied compounds or chemical advice. That account also distinguished the conceptual importance he assigned to the 1975 method from the larger citation count of the 1977 paper.
A powerful technique with visible limits
The original 1977 report did not promise that every band on a gel would be unambiguous. It discussed compressed bands, uncertain runs and the value of confirmation from another technique or the opposite strand. Its examples used bacteriophage φX174 DNA. The separate publication of a complete φX174 genome earlier in 1977 should not be merged with the later December chain-termination article.
Sanger shared the 1980 chemistry Nobel Prize with Walter Gilbert and Paul Berg and retired in 1983. Fluorescent detection, automated instruments and large genome projects depended on later developments by many teams. His name identifies a foundational sequencing approach, but it does not mean he personally built every later implementation. Cambridge’s official notice records his death on 19 November 2013. Reading the contemporary methods alongside his later recollection reveals a career of successive experimental improvements, acknowledged assistance and problems that remained open even when an influential method first appeared.
Quick answers
Frequently asked questions about Frederick Sanger
- Why did Frederick Sanger win two Nobel Prizes?
- The 1958 chemistry prize recognised protein structure research, particularly insulin. The 1980 shared chemistry award recognised contributions involving nucleic-acid sequencing.
- Who wrote the 1977 Sanger sequencing paper?
- Frederick Sanger, Steve Nicklen and Alan R. Coulson authored the paper on chain-terminating inhibitors.
- Was Sanger sequencing already a modern automated DNA test?
- No. The original method used laboratory reactions and gel-based detection. Later automation and large-scale sequencing involved further work by many researchers.
Keep exploring
Lives connected to this story
- Rosalind Franklin
Explore the separate question of molecular structure and the evidence supplied by diffraction.
- Barbara McClintock
Compare sequence determination with a different genetic question about chromosome behaviour and mobile elements.
Sources and further reading
Explore the evidence
These references support the biography and offer further reading. Official records, first-person accounts and independent reporting provide different perspectives; image records document attribution and licensing.
- 1. Nobel FoundationNobel Foundation: autobiographical account and 2005 addendum
The 2005 addendum compresses the sequencing chronology. The article uses the separately dated 1975 and 1977 papers when describing specific methods.
- 2. MRC Laboratory of Molecular BiologyMRC Laboratory of Molecular Biology: obituary, 2013
- 3. University of Cambridge ReporterUniversity of Cambridge Reporter: official death notice
- 4. Nature / PNAS; Memorial University scanSanger, Nicklen and Coulson, PNAS 1977: original scan
The five-page original paper was read. The account distinguishes its examples from the separate earlier 1977 complete-genome publication.
- 5. Current Contents / University of Pennsylvania archiveSanger, 1988: first-person Citation Classic commentary
Retrospective first-person testimony is identified as such. It supports collaboration and method-development history, not a substitute for the original experimental record.
- 6. PNAS / PubMed CentralPNAS / PubMed Central: article record
